NCT01729091 2025-05-09Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple MyelomaM.D. Anderson Cancer CenterPhase 2 Completed72 enrolled 14 charts